O-Show 2020 has been cancelled due to uncertainty surrounding the coronavirus (COVID-19) pandemic, as the organisers of other ophthalmic conferences...
Read moreThe University of Western Australia (UWA) has announced a new three-year postgraduate Doctor of Optometry program, which will begin in...
Read moreRANZCO will be forwarding to its members the latest coronavirus alert from the American Academy of Ophthalmology (AAO), providing updated...
Read moreAustralian drug regulators have approved a new aqueous, immunosuppressant for the treatment of moderate-to-severe dry eye. Cequa (ciclosporin 900 microgram/mL)...
Read moreA panel of glaucoma experts from ophthalmology, optometry, pharmacy and orthoptics, alongside patients living with the disease, will discuss the...
Read moreNew figures have revealed Australian optometrists performed a record number of Medicare consultations last year, while children’s vision assessments increased...
Read moreOptometry Australia (OA) has produced a free occupational optometry and safety eyewear guide to help eyecare professionals prevent patient injuries...
Read moreNovartis is working to ensure its newly-approved drug Beovu is accessible via the Pharmaceutical Benefits Scheme (PBS) at the earliest...
Read morePrednefrin Forte eye drops can now be prescribed to Aboriginal and Torres Strait Islander patients under the Pharmaceutical Benefits Scheme...
Read moreAustralia’s first myopia management survey has revealed single‐vision distance spectacles are the mainstay of myopia correction in school‐aged children, despite...
Read moreInsight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited